Role of ergoreflex activity in the pathogenesis of heart failure. The effectiveness of physical rehabilitation

Aim. To assess the change in ergoreflex activity in heart failure patients with reduced left ventricular systolic function in the study of the effectiveness of physical training (PT) with original regimen, compared with PT with conventionally estimated regimen.

Material and methods. Single-center open-label study of 297 patients with class III HF. The patients were divided into two groups: main group (MG) — patients, in whom the PT intensity was estimated based on lactate threshold (LT); comparison group (CG), in whom the PT intensity was estimated based on 60% VO_2peak. We analyzed ergoreflex activity, the relationship of ergoreflex with exercise tolerance (ET), routine systemic inflammation markers, clinical manifestations of HF, and ET based on VO_2peak.

Results. An increase in gait velocity at the LT level after 3 months of PT was registered in 94% (n=210) of the MG patients. After 3 months, the PT regimen was recalculated according to 60% VO_2реак; an increase in gait velocity at this level after 3 months of PT was registered in 70% of CG patients (n=35). The severity of HF decreased in both groups, but the dynamics was more pronounced in the MG, where class II was achieved by 75% of patients (in CG — 44%, p=0,003). In the MG, to a greater extent than in the CG, the ET increased. Ergoreflex activity (according to ΔV_E) decreased by ≥15% in 230 (97%) MG patients and in 31 (63%) patients with CG. After the completion of the PT period, when in some patients the HF severity decreased to class II, we revealed a direct association of the ergoreflex value (according to ΔV_E) with a greater severity of HF (r=-0,57, p=0,01) and the relationship between the decrease in ergoreflex activity (according to ΔV_E), an increase in VO_2LT (r=-0,55, p=0,001), VO_2peak (r=0,49, p=0,001), a decrease in monocyte count (r=0,63, p=0,01).

Conclusion. In stable patients with class III HF receiving the proper disease-modifying therapy, ergoreflex activity is increased and is associated with functional class, ET, and systemic inflammation activity. In the course of physical rehabilitation, a decrease in ergoreflex activity is accompanied by a decrease in functional class, an increase in EF, which is more pronounced with personalized aerobic exercise using LT regimen assessment.

1. McDonagh TA, Marco M, Marianna A, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. European Heart Journal. 202;42:36:3599-726.

2. Giordano A, Biondi-Zoccai G, Finizio F, et al. Characteristics and outcomes of MitraClip in octogenarians: Evidence from 1853 patients in the GIOTTO registry. Int J Cardiol. 2021:S0167-5273(21)01220-1. doi:10.1016/j.ijcard.2021.08.010.

3. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083.

4. Arutyunov GP, Kolesnikova EA, Begrambekova YL, et al. Recommendations for the appointment of physical training in patients with chronic heart failure. Journal of heart failure. 2017;18(1):41-66. (In Russ.)

5. Mezzani A. Cardiopulmonary Exercise Testing: Basics of Methodology and Measurements. Ann Am Thorac Soc. 2017;14:S3-S11. doi:10.1513/AnnalsATS.201612-997.

6. Piepoli M, Clark A, Volterrani M, et al. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation. 1996;93:940-52.

7. Lelyavina T, Sitnikova M, Beresina A, et al. New Approaches to Marking Stages of Incremental Physical Work by Example of Cardiopulmonary Exercise Testing. Journal of US-China Medical Science. 2014;11:9-13. doi:10.17265/1548-6648/2014.01.002.

8. Lelyavina T, Sitnikova M, Galenko V, et al. Аerobic training in heart failure patients with optimal heart failure therapy — a prospective randomized study. World Journal of Pharmaceutical Research. 2017;6:2:59-67.

9. Waterhouse DF, Cahill RA, Sheehan F, et al. Prediction of calculated future cardiovascular disease by monocyte count in asymptomatic population. VascHealthRiskManag. 2008;V.4(1):177-87.

10. Nozawa N, Hibi K, Endo M, et al. Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction. Circ J. 2010;74(7):1384-91. doi:10.1253/circj.CJ-09-0779.

11. Pardaens S, Vanderheyden M, Calders P, et al. Activation of the ergoreceptors in cardiac patients with and without heart failure. J Card Fail. 2014;20(10):747-54. doi:10.1016/j.cardfail.2014.07.006.

12. Ponikowski P, Chua T, Francis D, et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation. 2001;104(19):2324-30. doi:10.1161/hc4401.098491.

13. Notarius C, Millar P, Keir D, et al. Training heart failure patients with reduced ejection fraction attenuates muscle sympathetic nerve activation during mild dynamic exercise. Am J Physiol Regul Integr Comp Physiol. 2019;317:R503-R512. doi:10.1152/ajpregu.00104.2019.

14. Toth M, Miller M, Van Buren P, et al. Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels. J Physiol. 2012;590:1243-59.

15. Aimo A, Saccaro L, Chiara B, et al. The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease. European Journal of Heart Failure. 2021:10:1002-9.

16. Adamo L, Rocha-Resende C, Prabhu S, et al. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269-85. doi:10.1038/s41569-019-0315-x.

17. Shirazi L, Bissett J, Romeo F, et al. Role of Inflammation in Heart Failure. Curr Atheroscler Rep. 2017;19(6):27. doi:10.1007/s11883-017-0660-3.

18. Poole D, Rossiter H, Brooks G. The anaerobic threshold: 50+ years of controversy. Int J Mol Sci. 2021;599(3):737-67. doi:10.1113/JP279963.

19. Lelyavina TA, Galenko VL, Ivanova OA, et al. Clinical Response to Personalized Exercise Therapy in Heart Failure Patients with Reduced Ejection Fraction Accompanied by Skeletal Muscle Histological Alterations. Int J Mol Sci. 2019;20(21):5514. doi:10.3390/ijms20215514.

20. Ivanova OA, Ignatieva EV, Lelyavina TA, et al. Analysis of skeletal muscle transcriptome revealed the effect of physical training on the molecular mechanisms of regulation of growth and metabolism of muscle tissue in patients with chronic heart failure. Russian Journal of Cardiology. 2020;25(10):4132. (In Russ.) doi:10.15829/1560-4071-2020-4132.